The membrane attack complex of complement causes severe demyelination associated with acute axonal injury

被引:166
作者
Mead, RJ
Singhrao, SK
Neal, JW
Lassmann, H
Morgan, BP
机构
[1] Cardiff Univ, Dept Biochem Med, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
[2] Cardiff Univ, Dept Pathol, Complement Biol Grp, Cardiff CF14 4XN, S Glam, Wales
[3] Univ Vienna, Inst Brain Res, Vienna, Austria
关键词
D O I
10.4049/jimmunol.168.1.458
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement is implicated in pathology in the human demyelinating disease multiple sclerosis and in animal models that mimic the demyelination seen in multiple sclerosis. However, the components of the complement system responsible for demyelination in vivo remain unidentified. In this study, we show that C6-deficient (C6(-)) PVG/c rats, unable to form the membrane attack complex (MAC). exhibit no demyelination and significantly reduced clinical score in the Ab-mediated experimental autoimmune encephalomyelitis model when compared with matched C6-sufficient (C6(+)) rats. In C6(+) rats, perivenous demyelination appeared, accompanied by abundant mononuclear cell infiltration and axonal injury. Neither demyelination nor axonal damage was seen in C6(-) rats, whereas levels of mononuclear cell infiltration were equivalent to those seen in C6(+) rats. Reconstitution of C6 to C6(-) rats yielded pathology and clinical disease indistinguishable from that in C6(+) rats. We conclude that demyelination and axonal damage occur in the presence of Ab and require activation of the entire complement cascade, including MAC deposition. In the absence of MAC deposition, complement activation leading to opsonization and generation of the anaphylatoxins; C5a and C3a is insufficient to initiate demyelination.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 48 条
  • [1] APPLICATION OF TISSUE CULTURE TO STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS .2. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION
    APPEL, SH
    BORNSTEIN, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1964, 119 (02) : 303 - &
  • [2] Archelos JJ, 2000, ANN NEUROL, V47, P694, DOI 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.3.CO
  • [3] 2-N
  • [4] BENNUN A, 1982, J IMMUNOL, V129, P918
  • [5] THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS
    BENNUN, A
    WEKERLE, H
    COHEN, IR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) : 195 - 199
  • [6] Axonal pathology in myelin disorders
    Bjartmar, C
    Yin, XH
    Trapp, BD
    [J]. JOURNAL OF NEUROCYTOLOGY, 1999, 28 (4-5): : 383 - 395
  • [7] Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
    Brandt, J
    Pippin, J
    Schulze, M
    Hansch, GM
    Alpers, CE
    Johnson, RJ
    Gordon, K
    Couser, WG
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (02) : 335 - 343
  • [8] THE CONTRIBUTION OF TERMINAL COMPLEMENT COMPONENTS TO ACUTE AND HYPERACUTE ALLOGRAFT-REJECTION IN THE RAT
    BRAUER, RB
    BALDWIN, WM
    IBRAHIM, S
    SANFILIPPO, F
    [J]. TRANSPLANTATION, 1995, 59 (02) : 288 - 293
  • [9] BRAUER RB, 1993, J IMMUNOL, V151, P7240
  • [10] Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
    Calida, DM
    Constantinescu, C
    Purev, E
    Zhang, GX
    Ventura, ES
    Lavi, E
    Rostami, A
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (02) : 723 - 726